Novavax COVID-19 Vaccine Shows 90.4% Overall Efficacy
on June 14, 2021
30 Comments
Novavax might give America its fourth COVID-19 vaccine after a trial showed it is 90.4% overall efficient.
The vaccine also protects people from moderate and severe COVID-19 in the PREVENT-19 Phase 3 trial.





